Boral et al.23 took a different approach to identifying EpCAM-negative CTCs and performed multi-parametric flow cytometry using the DEPArray followed by RNA sequencing to define a transcriptomic signature of EpCAM-negative CTCs from 10 patients with breast cancer patients. Here, EPCAM is linked to breast carcinoma.